US2011070285A1PendingUtilityA1

Method of making flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time

43
Assignee: MEDTRONIC XOMED INCPriority: Sep 10, 2004Filed: Nov 30, 2010Published: Mar 24, 2011
Est. expirySep 10, 2024(expired)· nominal 20-yr term from priority
A61P 7/04A61L 2400/04A61L 24/0036A61P 17/02A61L 24/0042A61L 24/043A61L 2/081A61K 31/728A61L 2103/05
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a method of making flexible bioresorbable foam having hemostatic properties and a preselectable in-vivo residence time. A blend of crosslinked collagen blended and a hyaluronic acid component is prepared. The blend is mixed with water to form a suspension. The blend is freezed and lyophilized at less than about 0° C. Next, the blend is crosslinked. The product is then sterilized and chain scission is performed by bombardment with gamma rays or a beam of electrons.

Claims

exact text as granted — not AI-modified
1 . A method of making a flexible bioresorbable foam having a preselectable in-vivo residence time comprising the steps of:
 preparing a blend consisting of crosslinked collagen blended with a hyaluronic acid component,   mixing the blend with water to form a suspension;   freezing and lyophilizing the suspension at less than about 0° C.;   crosslinking the suspension to form a crosslinked product, and   sterilizing and performing chain scission on the product by means of bombardment with gamma rays or a beam of electrons.   
     
     
         2 . The method of making flexible bioresorbable foam of  claim 1 , wherein the lyophilization is performed at a temperature of less than about −40° C. 
     
     
         3 . The method of making flexible bioresorbable foam of  claim 1 , wherein the crosslinking is achieved by means of a method selected from dehydrothermal crosslinking and chemical crosslinking. 
     
     
         4 . The method of making flexible bioresorbable foam of  claim 1 , wherein crosslinking is achieved by use of formaldehyde vapor. 
     
     
         5 . The method of making flexible bioresorbable foam of  claim 4 , wherein the formaldehyde vapor is evacuated after a period of between about 2 hours and about 7 hours. 
     
     
         6 . The method of making flexible bioresorbable foam of  claim 1 , wherein the blend comprises between about 70 percent and about 90 percent by weight of the esterified hyaluronic acid. 
     
     
         7 . The method of making flexible bioresorbable foam composition of  claim 1 , wherein the sterilizing is performed by bombardment with gamma rays. 
     
     
         8 . The method of making flexible bioresorbable foam of  claim 1 , wherein the hyaluronic acid component is selected from hyaluronic acid, esterified hyaluronic acid and mixtures thereof. 
     
     
         9 . The method of making flexible bioresorbable foam of  claim 8 , wherein the esterified hyaluronic acid has an esterification level of between about 60 percent and about 70 percent. 
     
     
         10 . The method of making flexible bioresorbable foam of  claim 9 , wherein the esterified hyaluronic acid is selected from the group consisting of a benzyl ester of hyaluronic acid, an ethyl ester of hyaluronic acid and mixtures thereof. 
     
     
         11 . The method of making flexible bioresorbable foam of  claim 1 , wherein the crosslinked collagen is a microfibrillar collagen. 
     
     
         12 . The method of making flexible bioresorbable foam of  claim 1 , wherein the preselectable residence time ranges between about 5 days and about 14 days. 
     
     
         13 . A method of making a flexible bioresorbable foam having a preselectable in-vivo residence time, wherein the method comprises the steps of:
 preparing a blend consisting of crosslinked collagen blended with a hyaluronic acid component,   mixing the blend with water to form a mixture;   freezing the mixture;   lyophilizing the mixture;   crosslinking the mixture to form a crosslinked product, and   sterilizing and performing chain scission the product.   
     
     
         14 . The method of making flexible bioresorbable foam of  claim 13 , wherein crosslinking is achieved using formaldehyde vapor. 
     
     
         15 . The method of making flexible bioresorbable foam of  claim 14 , wherein the formaldehyde vapor is evacuated after a period of between about 2 hours and about 7 hours. 
     
     
         16 . The method of making flexible bioresorbable foam of  claim 13 , wherein the blend comprises between about 70 percent and about 90 percent by weight of the esterified hyaluronic acid. 
     
     
         17 . The method of making flexible bioresorbable foam composition of  claim 13 , wherein the sterilizing is performed by bombardment with gamma rays. 
     
     
         18 . The method of making flexible bioresorbable foam of  claim 13 , wherein the hyaluronic acid component is selected from hyaluronic acid, esterified hyaluronic acid and mixtures thereof. 
     
     
         19 . The method of making flexible bioresorbable foam of  claim 18 , wherein the esterified hyaluronic acid has an esterification level of between about 60 percent and about 70 percent. 
     
     
         20 . The method of making flexible bioresorbable foam of  claim 19 , wherein the esterified hyaluronic acid is selected from the group consisting of a benzyl ester of hyaluronic acid, an ethyl ester of hyaluronic acid and mixtures thereof. 
     
     
         21 . The method of making flexible bioresorbable foam of  claim 13 , wherein the crosslinked collagen is a microfibrillar collagen.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.